Study of CTS-1027 in Combination With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Null-Responders
Clinical trial NCT01051921 · COMPLETED
Trial details
- NCT number
- NCT01051921
- Sponsor
- Conatus Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-11-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.